Increased intracellular calcium and altered phorbol dibutyrate binding to intact platelets in young subjects with insulin-dependent and non-insulin- dependent diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 46, Issue 8, 1997, Pages 949-953

  Takaya, Junji ^a   Iwamoto, Yukihisa ^a   Higashino, Hirohiko ^a   Ishihara, Reiko ^a   Kobayashi, Yohnosuke ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL DIBUTYRATE; PROTEIN KINASE C;

ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THROMBOCYTE;

EID: 0030755440     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90085-8     Document Type: Article

References (34)

1. +-pumping activity in erythrocytes from IDDM and NIDDM subjects. Diabetes 38:825-831, 1989
2. De Maria R, Todaro M, Stassi G, et al: Defective T cell receptor/CD3 complex signaling in human type I diabetes. Eur J Immunol 24:999-1002, 1994
3. Häring HU: The insulin receptor: Signaling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 34:848-861, 1991
4. Takayama S, White MF, Kahn CR: Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 263:3440-3447, 1988
5. Bollag GE, Roth RA, Beaudoin J, et al: Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA 83:5822-5824, 1986
6. Lewis RE, Cao L, Perregaux D, et al: Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. Biochemistry 29:1807-1813, 1990
7. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614, 1992
8. 2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C. Biochem J 255:309-318, 1988
9. Ishii H, Umeda F, Hashimoto T, et al: Changes in phosphoinositide turnover, mobilization, and protein phosphorylation in platelets from NIDDM patients. Diabetes 39:1561-1568, 1990
10. Putney JW Jr, Bird GSJ: The signal for capacitative calcium entry. Cell 75:199-201, 1993
11. Levy J, Gavin JR III, Sowers JR: Diabetes mellitus: A disease of abnormal cellular calcium metabolism? Am J Med 96:260-273, 1994
12. Winegrad AL: Does a common mechanism induce the diverse complications of diabetes? Diabetes 36:396-406, 1986
13. Lee TS, Saltsman KA, Ohashi H, et al: Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86:5141-5145, 1989
14. Trovati M, Mularoni EM, Burzacca S, et al: Impaired insulin-induced platelet antiaggregating effect in obesity and obese NIDDM patients. Diabetes 44:1318-1322, 1995
15. García Frade LJ, De La Calle H, Alava I, et al: Diabetes mellitus as a hypercoagulable state: Its relationship with fibrin fragments and vascular damage. Thromb Res 47:533-540, 1987
16. Hannun YA, Loomis CR, Merrill AH Jr, et al: Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 261:12604-12609, 1986
17. Sharkey NA, Leach KL, Blumberg PM: Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc Natl Acad Sci USA 81:607-610, 1984
18. Goodwin BJ, Weinberg JB: Receptor-mediated modulation of human monocyte, neutrophil, lymphocyte, and platelet function by phorbol diesters. J Clin Invest 70:699-706, 1982
19. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
20. 2+. Biochem J 278:411-415, 1991
21. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985
22. Akai T: Glycosylated hemoglobin, in Vensonic Seminar Proceeding 1. Tokyo, Japan, Kyoto Daiichi Kagaku, 1982, pp 17-25
23. Akanuma H, Ogawa K, Lee YS, et al: Reduced levels of plasma 1,5-anhydroglucitol in diabetic patients. J Biochem 90:157-162, 1981
24. Johnson RN, Metcalf PA, Baker JR: Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127:87-95, 1982
25. + antiport activation by endothelin in human skin fibroblasts. FEBS Lett 256:38-42, 1989
26. Draznin B, Lewis D, Houlder N, et al: Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. Endocrinology 125:2341-2349, 1989
27. + transport in diabetes mellitus. Diabetes 39:850-854, 1990
28. Tschöpe D, Rösen P, Gries FA: Increase in the cytosolic concentration of calcium in platelets of diabetics type II. Thromb Res 62:421-428, 1991
29. Salans LB, Cushman SW, Weismann RE: Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest 52:929-941, 1973
30. Pedersen O, Kahn CR, Kahn BB: Divergent regulation of the Glut1 and Glut4 glucose transporters in isolated adipocytes from Zucker rats. J Clin Invest 89:1964-1973, 1992
31. Hall JE: Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 23:381-394, 1994
32. Erne P, Bolli P, Burgisser E, et al: Correlation of platelet calcium with blood pressure. N Engl J Med 310:1084-1088, 1984
33. + antiport in the development of hypertension and insulin resistance. J Am Soc Nephrol 3:1049-1063, 1992
34. Kikkawa R, Haneda M, Uzu T, et al: Translocation of protein kinase C α and ζ in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37:838-841, 1994